Скачать или смотреть HIMS Stock Price Prediction: Buy the Dip or Get Out Now? 🚨

Hims & Hers Health (HIMS) stock just faced its most brutal week of the year, plummeting 16% in after-hours trading following a massive DOJ referral. In this video, we break down why the FDA is cracking down on compounded GLP-1s and what Novo Nordisk's legal moves mean for your portfolio. We analyze the $19 support level and whether Hims' strategic pivot away from weight-loss pills is a death blow or a necessary evolution before their February earnings call.

Interest & Market Data:
HIMS stock analysis, Hims & Hers stock news today, HIMS stock prediction 2026, why is HIMS stock dropping, HIMS vs Novo Nordisk, compounded Wegovy FDA news, HIMS earnings date, best telehealth stocks to buy, HIMS price target February 2026, HIMS stock DOJ investigation, is HIMS stock a buy.

Video Chapters:
00:00 HIMS Stock: Why the 16% Crash Happened
01:45 DOJ & FDA vs. Compounded Weight-Loss Drugs
03:20 Financial Health: P/E Ratio & Valuation Analysis
05:10 Price Prediction & February 23rd Earnings Outlook

#HIMS #HimsAndHers #StockMarketNews #WeightLossDrugs #Investing #Telehealth #StockAlert